Reneo Pharmaceuticals (RPHM) Q3 2024 Earnings

13AugConfirmed
Q2 2023
Q3 2023
Q2 2024
Q3 2024
-1.6
-1.15
-0.7
-0.25

Details

Expected EPS
-1
Actual EPS
-1.6
Surprise EPS
-0.6
Surprise Percent
+60%

Description

Reneo Pharmaceuticals (RPHM) has reported earnings of -1.6 per share for Q3 2024.

0 Comments

Share your thoughts